Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species
Xiao‐Jing Zhang(Wuhan University), Hongliang Li(Jiangnan University), Qingbo Xu(Southwest Medical University), Haibo Xu(Qiqihar Medical University), Manli Hu(Wuhan University), Zhao V. Wang(Southwestern Medical Center), Ruifeng Tian(Harbin Engineering University), Jingjing Cai(Anhui Institute of Architectural Research and Design), Zhi‐Gang She(Wuhan University), Dating Sun(Wuhan University), Guojun Zhao(Wuhan University), Hailong Yang(Gannan Medical University), Xinliang Ma(Thomas Jefferson University), Zhibing Lu(Wuhan University), Xu Cheng(Tianjin University of Traditional Chinese Medicine), Zan Huang(Guangzhou Maritime College), Hui Xiang(Wuhan University), Rufang Liao(Wuhan University), Peter P. Liu(University of Ottawa), Peng Zhang(Shaoxing People's Hospital), Guannan Meng(Wuhan University), Lijun Shen(Wuhan University), Haiping Wang(Wuhan University), Lan Bai(Shanghai Jiao Tong University), Yibin Wang(Central South University), Song Tian(Wuhan University), Lihua Zhu(Jiangxi University of Science and Technology), Yongping Huang(Wuhan University), Junpeng Ma(Nanchang University), Xiaolan Liu(Qiqihar University), Xin Zhang(Wuhan University), Shanyu Gan(Wuhan University), Toujun Zou(Wuhan University), Yan‐Xiao Ji(Wuhan University)
Cited by 105
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777